Broker│ Rating│ Target Price (HKD)Nomura│Buy│157.07Morgan Stanley│Overweight│155JPMorgan│150Goldman Sachs│ Buy (Conviction List Buy)│149.7CLSA│ Conviction Outperform│149.3Broker | OpinionNomura | 1Q26 results were strong, an outstanding quarterly resultsMorgan Stanley | Share price is expected to rise over the next 30 days on higher earnings forecasts and results guidanceJPMorgan | 1Q25 results beat expectations across the board, with margins wideningGoldman Sachs | Improved operational efficiency drove 1Q26 revenue and earnings well above forecasts; Strong profitability maintained despite foreign exchange headwindsCLSA | 1Q26 results beat estimations and order intake remained solid, further enhancing visibility into future resultsRelated News CLSA: WuXi AppTec (02359.HK) Delivers Strong 1Q26 Results, Named Sector Top Pick
AASTOCKS Financial News